CORC  > 中南大学
Population pharmacokinetics of voriconazole and CYP2C19 polymorphisms for optimizing dosing regimens in renal transplant recipients
Lin, Xiao-bin; Li, Zi-wei; Yan, Miao*; Zhang, Bi-kui; Liang, Wu; Wang, Feng; Xu, Ping; Xiang, Da-xiong; Xie, Xu-biao; Yu, Shao-jie
刊名British Journal of Clinical Pharmacology
2018
卷号84期号:7页码:1587-1597
关键词CYP2C19 polymorphism dosing simulation population pharmacokinetics renal transplant recipients voriconazole
ISSN号1365-2125
DOI10.1111/bcp.13595
URL标识查看原文
WOS记录号WOS:000435440600021
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/3342356
专题中南大学
作者单位1.[Li, Zi-wei
2.Yan, Miao
3.Xiang, Da-xiong
4.Zhang, Bi-kui
5.Lin, Xiao-bin
6.Xu, Ping
7.Wang, Feng] Cent S Univ, Dept Pharm, Xiangya Hosp 2, Changsha 410011, Hunan, Peoples R China.
推荐引用方式
GB/T 7714
Lin, Xiao-bin,Li, Zi-wei,Yan, Miao*,et al. Population pharmacokinetics of voriconazole and CYP2C19 polymorphisms for optimizing dosing regimens in renal transplant recipients[J]. British Journal of Clinical Pharmacology,2018,84(7):1587-1597.
APA Lin, Xiao-bin.,Li, Zi-wei.,Yan, Miao*.,Zhang, Bi-kui.,Liang, Wu.,...&Peng, Feng-hua*.(2018).Population pharmacokinetics of voriconazole and CYP2C19 polymorphisms for optimizing dosing regimens in renal transplant recipients.British Journal of Clinical Pharmacology,84(7),1587-1597.
MLA Lin, Xiao-bin,et al."Population pharmacokinetics of voriconazole and CYP2C19 polymorphisms for optimizing dosing regimens in renal transplant recipients".British Journal of Clinical Pharmacology 84.7(2018):1587-1597.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace